发明名称 Piperazine derivatives as 5-ht antagonists
摘要 This invention concerns compounds of formula (I) <IMAGE> (I) where A is a C1 or C2 alkylene chain optionally substituted by lower alkyl; Z is a bicyclic oxygen-containing aryl radical (e.g. 2,3-dihydro-1,4-benzodioxin-5-yl); R is hydrogen or lower alkyl; R1 is aryl or aryl(lower)alkyl; R2 is hydrogen or lower alkyl; and R3 is hydrogen, an alkyl group of 1 to 10 carbon atoms, cycloalkyl of 3 to 12 carbon atoms; cycloalkyl(lower)alkyl, aryl or aryl(lower)alkyl or R2 and R3 together with the nitrogen atom to which they are both attached represent a saturated heterocyclic ring which may contain a further hetero atom, and the pharmaceutically acceptable acid addition salts thereof. The compounds are 5-HT1A-antagonists which may be used, for example, in treating anxiety.
申请公布号 US5710149(A) 申请公布日期 1998.01.20
申请号 US19960731953 申请日期 1996.10.23
申请人 JOHN WYETH & BROTHER, LTD. 发明人 CLIFFE, IAN ANTHONY
分类号 A61K31/335;A61K31/34;A61K31/343;A61K31/35;A61K31/352;A61K31/353;A61K31/357;A61K31/39;A61K31/535;A61K31/538;A61K31/55;A61P9/12;A61P13/02;A61P15/00;A61P25/00;A61P25/20;A61P25/24;A61P25/26;A61P43/00;C07D265/36;C07D295/10;C07D307/79;C07D311/08;C07D311/20;C07D311/22;C07D311/58;C07D317/46;C07D317/66;C07D319/18;C07D319/20;C07D321/10;C07D327/06;C07D405/02;C07D405/04;C07D411/02;C07D413/02;(IPC1-7):A61K31/55;A61K31/495;C07D405/14;C07D405/10 主分类号 A61K31/335
代理机构 代理人
主权项
地址